Kerala Ayurveda [KERALAYUR] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison
Kerala Ayurveda
BSE
Loading...
Divi's Laboratories
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Kerala Ayurveda wins in 7 metrics, Divi's Laboratories wins in 12 metrics, with 0 ties. Divi's Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Kerala Ayurveda | Divi's Laboratories | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 617.16 | 67.57 | Divi's Laboratories |
| Price-to-Book Ratio | 56.71 | 10.40 | Divi's Laboratories |
| Debt-to-Equity Ratio | 548.18 | 0.03 | Divi's Laboratories |
| PEG Ratio | 1.28 | 2.55 | Kerala Ayurveda |
| EV/EBITDA | 766.78 | 49.66 | Divi's Laboratories |
| Profit Margin (TTM) | -9.83% | 23.89% | Divi's Laboratories |
| Operating Margin (TTM) | 9.54% | 25.60% | Divi's Laboratories |
| EBITDA Margin (TTM) | 9.54% | 25.60% | Divi's Laboratories |
| Return on Equity | 140.14% | 14.64% | Kerala Ayurveda |
| Return on Assets (TTM) | -10.84% | 12.94% | Divi's Laboratories |
| Free Cash Flow (TTM) | $-84.95M | $2.15B | Divi's Laboratories |
| Dividend Yield | N/A | 0.91% | N/A |
| 1-Year Return | 62.60% | -5.14% | Kerala Ayurveda |
| Price-to-Sales Ratio (TTM) | 4.30 | 16.13 | Kerala Ayurveda |
| Enterprise Value | $5.52B | $1,522.01B | Divi's Laboratories |
| EV/Revenue Ratio | 4.17 | 15.77 | Kerala Ayurveda |
| Gross Profit Margin (TTM) | 75.65% | 60.33% | Kerala Ayurveda |
| Revenue per Share (TTM) | $113 | $363 | Divi's Laboratories |
| Earnings per Share (Diluted) | $-10.04 | $86.82 | Divi's Laboratories |
| Beta (Stock Volatility) | 0.02 | 0.18 | Kerala Ayurveda |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Kerala Ayurveda vs Divi's Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Kerala Ayurveda | 1.84% | 1.65% | -5.00% | -19.43% | 33.62% | 4.36% |
| Divi's Laboratories | 4.77% | 2.26% | -3.33% | -15.42% | 10.79% | -4.06% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Kerala Ayurveda | 62.60% | 536.50% | 793.09% | 828.34% | 546.83% | 1,139.46% |
| Divi's Laboratories | -5.14% | 63.08% | 80.80% | 444.71% | 1,530.25% | 8,023.95% |
News Based Sentiment: Kerala Ayurveda vs Divi's Laboratories
Kerala Ayurveda
News based Sentiment: NEGATIVE
The month was dominated by disappointing financial results, including a significant annual loss and a negative P/E ratio. While there are positive aspects like the growth strategy and market recognition, the overall narrative is one of financial distress and uncertainty, making it a significant month for investors to reassess their positions.
Divi's Laboratories
News based Sentiment: MIXED
Divi's Laboratories reported strong quarterly results and is strategically diversifying its revenue base, but faces operational challenges and mixed analyst sentiment. The technical indicators also present a cautious outlook, creating a complex investment narrative with both opportunities and risks.
Performance & Financial Health Analysis: Kerala Ayurveda vs Divi's Laboratories
| Metric | KERALAYUR | DIVISLAB |
|---|---|---|
| Market Information | ||
| Market Cap | ₹5.52B | ₹1.61T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 9,497 | 455,187 |
| 90 Day Avg. Volume | 28,584 | 395,686 |
| Last Close | ₹467.05 | ₹6,104.50 |
| 52 Week Range | ₹305.00 - ₹625.00 | ₹4,955.00 - ₹7,071.50 |
| % from 52W High | -25.27% | -13.67% |
| All-Time High | ₹625.00 (Jul 01, 2025) | ₹7,071.50 (Jul 08, 2025) |
| % from All-Time High | -25.27% | -13.67% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.38% | 0.14% |
| Quarterly Earnings Growth | 5.29% | 0.27% |
| Financial Health | ||
| Profit Margin (TTM) | -0.10% | 0.24% |
| Operating Margin (TTM) | 0.10% | 0.26% |
| Return on Equity (TTM) | 1.40% | 0.15% |
| Debt to Equity (MRQ) | 548.18 | 0.03 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹8.36 | ₹563.87 |
| Cash per Share (MRQ) | ₹3.27 | ₹132.86 |
| Operating Cash Flow (TTM) | ₹43.75M | ₹19.67B |
| Levered Free Cash Flow (TTM) | ₹-139,590,000 | ₹21.91B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.91% |
| Last 12-Month Dividend | N/A | ₹60.00 |
Valuation & Enterprise Metrics Analysis: Kerala Ayurveda vs Divi's Laboratories
| Metric | KERALAYUR | DIVISLAB |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 617.16 | 67.57 |
| Forward P/E | N/A | 104.19 |
| PEG Ratio | 1.28 | 2.55 |
| Price to Sales (TTM) | 4.30 | 16.13 |
| Price to Book (MRQ) | 56.71 | 10.40 |
| Market Capitalization | ||
| Market Capitalization | ₹5.52B | ₹1.61T |
| Enterprise Value | ₹5.52B | ₹1.52T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.17 | 15.77 |
| Enterprise to EBITDA | 766.78 | 49.66 |
| Risk & Other Metrics | ||
| Beta | 0.02 | 0.18 |
| Book Value per Share (MRQ) | ₹8.36 | ₹563.87 |
Financial Statements Comparison: Kerala Ayurveda vs Divi's Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | KERALAYUR | DIVISLAB |
|---|---|---|
| Revenue/Sales | ₹286.12M | ₹24.10B |
| Cost of Goods Sold | ₹69.68M | ₹9.56B |
| Gross Profit | ₹216.44M | ₹14.54B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-58.38M | ₹6.17B |
| EBITDA | ₹52.88M | ₹8.48B |
| Pre-Tax Income | ₹28.11M | ₹7.33B |
| Income Tax | ₹7.83M | ₹1.88B |
| Net Income (Profit) | ₹20.28M | ₹5.45B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | KERALAYUR | DIVISLAB |
|---|---|---|
| Cash & Equivalents | ₹33.89M | ₹4.15B |
| Total Current Assets | ₹407.67M | ₹100.81B |
| Total Current Liabilities | ₹879.75M | ₹14.52B |
| Long-Term Debt | ₹222.20M | ₹20.00M |
| Total Shareholders Equity | ₹-99.60M | ₹149.69B |
| Retained Earnings | N/A | ₹134.00B |
| Property, Plant & Equipment | ₹10.08M | ₹3.19B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | KERALAYUR | DIVISLAB |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | KERALAYUR | DIVISLAB |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 9,497 | 455,187 |
| Average Daily Volume (90 Day) | 28,584 | 395,686 |
| Shares Outstanding | 12.03M | 265.47M |
| Float Shares | 5.29M | 120.77M |
| % Held by Insiders | 0.58% | 0.52% |
| % Held by Institutions | 0.00% | 0.29% |
Dividend Analysis & Yield Comparison: Kerala Ayurveda vs Divi's Laboratories
| Metric | KERALAYUR | DIVISLAB |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹60.00 |
| Last 12-Month Dividend Yield | N/A | 0.91% |
| 3-Year Avg Annual Dividend | N/A | ₹50.00 |
| 3-Year Avg Dividend Yield | N/A | 0.70% |
| 3-Year Total Dividends | N/A | ₹150.00 |
| Ex-Dividend Date | N/A | Jul 25, 2025 |